Physician profile
Robert Bruce Cameron
NPI 1003859539
$1,803.60
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,399 · 2020: $405.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $488.84 | 2019-2020 | |
| Abbvie INC. | $368.38 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $229.26 | 2019-2020 | |
| Janssen Biotech, INC. | $225.48 | 2019-2020 | |
| Pfizer INC. | $134.83 | 2019-2020 | |
| Vivus LLC | $100.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $75.08 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $62.47 | 2019-2020 | |
| Allergan, INC. | $48.90 | 2020 | |
| Concordia Pharmaceuticals INC. | $17.95 | 2019 | |
| Redhill Biopharma INC. | $14.79 | 2020 | |
| Shire North American Group INC | $13.23 | 2019 | |
| Shionogi INC | $12.30 | 2019 | |
| Qol Medical, LLC | $11.30 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.